Logo image
Back
Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010
Journal article   Open access   Peer reviewed

Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010

J.D. Turnidge, T. Gottlieb, D.H. Mitchell, G.W. Coombs, J.C. Pearson and J.M. for the Australian Group on Antimicrobial Resistance Bell
Communicable diseases intelligence quarterly report, Vol.37(3), pp.E219-E223
2013
pdf
Antimicrobial_Resistance_Community-onset_Gram-negative_Surveillance.pdfDownloadView
Published (Version of Record) Open Access
url
Free to Read *No subscription requiredView

Abstract

The Australian Group on Antimicrobial Resistance (AGAR) performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2010 survey focussed on community-onset infections, examining isolates from urinary tract infections from patients presenting to outpatient clinics, emergency departments or to community practitioners. Two thousand and ninety-two Escherichia coli, 578 Klebsiella species and 268 Enterobacter species were tested using a commercial automated method (Vitek 2, BioMérieux) and results were analysed using Clinical and Laboratory Standards Institute breakpoints from January 2012. Of the key resistances, non-susceptibility to the third-generation cephalosporin, ceftriaxone, was found in 3.2% of E. coli and 3.2%–4.0% of Klebsiella spp. Non-susceptibility rates to ciprofloxacin were 5.4% for E. coli, 1.0%–2.3% for Klebsiella spp., and 2.5%–6.6% in Enterobacter spp, and resistance rates to piperacillin-tazobactam were 2.8%, 3.2%–6.9%, and 16.8%–18.0% for the same 3 groups respectively. Only 3 strains, 2 Klebsiella spp. and 1 Enterobacter spp, were shown to harbour a carbapenemase (IMP-4).

Details

Metrics

125 File views/ downloads
43 Record Views
Logo image